BioCentury | Jun 27, 2019
Financial News

Syncona reaps tenfold return from Blue Earth exit

...happy with Blue Earth's profitability based on sales of flagship prostate cancer imaging diagnostic Axumin [18f]-fluciclovine...
BioCentury | Oct 6, 2017
Clinical News

Blue Earth reports Phase III data of imaging agent for prostate cancer treatment planning

...interim analysis, it halted enrollment in the Phase III Falcon trial of imaging agent Axumin [18F]-fluciclovine...
...data from 85 patients showed that 61% had their management plan changed after results of Axumin...
...Blue Earth Diagnostics Ltd. , London, U.K. General Electric Co. (NYSE:GE), Fairfield, Conn. Product: Axumin [18F]-fluciclovine...
BioCentury | Mar 29, 2017
Clinical News

Axumin regulatory update

...EMA’s CHMP recommended approval of an MAA from Blue Earth for Axumin [18F]-fluciclovine as a diagnostic...
...Ltd. , London, U.K. General Electric Co. (NYSE:GE), Fairfield, Conn. Product: Axumin [18F]-fluciclovine Business: Diagnostic Julian Zhu [18F]-fluciclovine Axumin Blue...
BioCentury | Jul 11, 2016
Finance

Shedding red

...sclerosis in adults Blue Earth Diagnostics Ltd. / General Electric Co. (NYSE:GE) FDA approves Axumin [18F]-fluciclovine...
BioCentury | Jun 13, 2016
Company News

Blue Earth Diagnostics, Siemens sales and marketing update

...Blue Earth and PETNET Solutions Inc. launched Axumin [18F]-fluciclovine injection in the U.S. as a diagnostic...
...Earth holds exclusive rights outside of China and some Asian countries to develop and commercialize Axumin...
BioCentury | Jun 6, 2016
Clinical News

Axumin [18F]-fluciclovine regulatory update

...FDA approved an NDA from Blue Earth for Axumin [18F]-fluciclovine as a diagnostic PET imaging agent...
...Blue Earth Diagnostics Ltd. , London, U.K. General Electric Co. (NYSE:GE), Fairfield, Conn. Product: Axumin [18F]-fluciclovine...
BioCentury | Apr 11, 2016
Clinical News

[18F]-fluciclovine: Phase III started

...Blue Earth began the open-label, U.K. Phase III FALCON trial to evaluate [18F]-fluciclovine in 180 patients...
...Earth Diagnostics Ltd. , London, U.K. General Electric Co. (NYSE:GE), Fairfield, Conn. Product: [18F]-fluciclovine ( FACBC...
BioCentury | Dec 21, 2015
Clinical News

[18F]-fluciclovine regulatory update

...FDA accepted and granted Priority Review to an NDA from Blue Earth for [18F]-fluciclovine PET imaging...
...Earth Diagnostics Ltd. , London, U.K. General Electric Co. (NYSE:GE), Fairfield, Conn. Product: [18F]-fluciclovine ( FACBC...
BioCentury | Mar 17, 2014
Company News

Blue Earth Diagnostics, General Electric deal

...rights outside of China and undisclosed Asian territories to develop and commercialize PET imaging agent [18F]-fluciclovine...
Items per page:
1 - 9 of 9